Pharmaceutical Manufacturing processes are getting more complex, while regulation calls for monitoring and control of process variability. Data plays a crucial role in ensuring process control but can also be used to derive further insights to improve process designs.
In this webinar, we will reflect on current practices and regulations around process validation, providing insights into challenges and success factors towards implementation of Continued Process Verification Programs. Guided by an illustrative use case, we will touch upon the choice of technology and data, as well as seamless integration via streamlined, cross-disciplinary project approaches.
We conclude by further illustration of the potential of data, once gathered in structured form, to derive insights that underpin continual improvement in process designs – thus completing the process life cycle, guided by data and empirical evidence.
We are conducting this event in partnership with our cooperation partner, ValGenesis. ValGenesis, a leading solutions provider on the mission to digitalize regulatory processes in the Life Sciences, and d-fine, a European consulting firm supporting its clients in complex technological and analytical projects.
Join us for this webinar about the potential in digital transformation in this practical context of use! Digitalization is more than overcoming paper – it is a way of thinking processes end-to-end, guided by data.
28 November 2024
15:00 – 16:00 (UTC+1)
MS Teams
Host
Martin Heitmann (Senior Manager & Expert in Life Sciences and Healthcare Digitalization at d-fine) with further contributions from d-fine and ValGenesis
Agenda Topics
- Background of process validation and continued process verification (CPV)
- Challenges of implementing CPV programs
- Building blocks for successful CPV programs
- Re-use of data – from continued process verification to valuable insights
- Opportunity for Q&A
To register to our Webinar, please click below to access the registration form.
Register now
